A study for a 73 year old woman who takes Enbrel, Arthrotec, Valsartan - from FDA reports

330 females aged 73 (±5) who take the same drugs are studied. This is a personalized study for a 73 year old female patient who has Rheumatoid Arthritis, High Blood Pressure. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Jan, 22, 2019

330 females aged 73 (±5) who take Enbrel, Arthrotec, Valsartan are studied.

Number of reports submitted per year:

Enbrel, Arthrotec, Valsartan for a 73-year old woman.

Information of the patient in this study:

  • Age: 73
  • Gender: female
  • Conditions: Rheumatoid Arthritis, High Blood Pressure
  • Drugs taken:
    • Enbrel (etanercept)
    • Arthrotec (diclofenac sodium; misoprostol)
    • Valsartan (valsartan)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Taste Loss: 0 (0% of females aged 73 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  1. Therapeutic response unexpected
  2. Pre-existing condition improved
  3. Joint pain
  4. Rash papular (redness with papule)
  5. Rectal haemorrhage (bleeding from anus)
  6. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  7. Feeling hot
  8. Septic shock (shock due to blood infection)
  9. Eye infection
  10. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
1 - 6 months:
  1. Visual impairment
  2. Coronary heart disease (narrowing or blockage of the coronary arteries)
  3. Joint swelling
  4. Breast pain
  5. Hypersensitivity
  6. Blood glucose increased
  7. Cataract (clouding of the lens inside the eye)
  8. Hypophagia (reduced food intake)
  9. Activities of daily living impaired
  10. Hepatic function abnormal
6 - 12 months:
  1. Drug ineffective
  2. Glaucoma (increased fluid pressure in the eye with vision loss)
  3. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  4. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
  5. Drug intolerance (drug sensitivity)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Treatment failure
  8. Drug hypersensitivity
  9. Synovitis (inflammation of the synovial membrane)
  10. Glomerulonephritis rapidly progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function)
1 - 2 years:
  1. Constipation
  2. Renal injury (kidney injury)
  3. Chronic kidney disease
  4. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
  5. Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
  6. Secretion discharge
  7. Feeling hot
  8. Parathyroid gland enlargement
  9. Fall
  10. Pulmonary tuberculosis (lungs tuberculosis)
2 - 5 years:
  1. Drug effect decreased
  2. Ovarian cancer (cancer of ovary)
  3. Pain in extremity
  4. Eye infection
  5. Metastases to lymph nodes (cancer spreads to lymph node)
  6. Neck pain
  7. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  8. Back pain
  9. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  10. Joint pain
5 - 10 years:
  1. Chronic kidney disease
  2. Constipation
  3. Renal injury (kidney injury)
  4. Death
  5. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  6. Mesenteric panniculitis (a rare benign inflammatory condition of unknown origin that affects the mesenteric fat)
  7. Gait disturbance
  8. Cartilage injury
  9. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  10. Injection site pain
10+ years:
  1. Breast cancer
  2. Drug effect decreased
  3. Post procedural infection
  4. Investigation abnormal
  5. Joint swelling
  6. Arthropathy
  7. Hepatic enzyme increased
  8. Urinary tract infection
  9. Joint pain
  10. Skin disorder (skin disease)
not specified:
  1. Drug ineffective
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Drug intolerance (drug sensitivity)
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  5. Glaucoma (increased fluid pressure in the eye with vision loss)
  6. Drug hypersensitivity
  7. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
  8. Synovitis (inflammation of the synovial membrane)
  9. Treatment failure
  10. Pneumonia

Top conditions involved for these people *:

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 18 people, 5.45%
  2. Osteoporosis (bones weak and more likely to break): 17 people, 5.15%
  3. Colon Cancer : 12 people, 3.64%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 2.73%
  5. Supplementation Therapy : 9 people, 2.73%
  6. Anticoagulant Therapy : 6 people, 1.82%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 1.52%
  8. Diabetes : 5 people, 1.52%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 1.52%
  10. High Blood Cholesterol : 5 people, 1.52%

Top co-used drugs for these people *:

  1. Methotrexate (55 people, 16.67%)
  2. Orencia (55 people, 16.67%)
  3. Xalatan (51 people, 15.45%)
  4. Cimzia (49 people, 14.85%)
  5. Actemra (45 people, 13.64%)
  6. Folic Acid (44 people, 13.33%)
  7. Calcium (42 people, 12.73%)
  8. Plaquenil (41 people, 12.42%)
  9. Arava (39 people, 11.82%)
  10. Prednisone (32 people, 9.70%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!